Caption Management, LLC Cel Sci Corp Put Options Transaction History

Caption Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 12, 2021	SELL	$7.64 - $12.49 $424,020 - $693,195	-55,500 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$8.68 - $27.49 $3.42 Million - $10.8 Million	-394,500 Reduced 87.67%	55,500 $482,000
Q3 2020 Nov 16, 2020	BUY	$11.69 - $14.54 $2.9 Million - $3.61 Million	248,300 Added 123.1%	450,000 $5.74 Million
Q2 2020 Aug 14, 2020	BUY	$9.75 - $17.6 $1.97 Million - $3.55 Million	201,700 New	201,700 $3.01 Million
Q4 2019 Feb 13, 2020	SELL	$6.71 - $9.55 $201,300 - $286,500	-30,000 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$6.0 - $9.6 $180,000 - $288,000	30,000 New	30,000 $268,000

27.1K

150K

Ticker CVM
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,367,500
Market Cap $26.9M
Description
CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.